[1] 于乐成,茅益民,陈成伟.药物性肝损伤诊治指南.临床肝胆病杂志,2015,31:1752-1769.
[2] Bjornsson E,Olsson R. Suspected drug - induced liver fatalitiesreported to the WHO database. Dig Liver Dis,2006,38: 33- 38.
[3] 郑艺兰,金海燕.药物性肝损伤的研究进展.世界最新医学信息文摘,2015,15:162-163, 168.
[4] Björnsson ES,Bergmann OM,Bjornsson HK,et al. Incidence,presentation,and outcomes in patients with drug-induced liver injury in the general population of lceland. Gastroenterology,2013,144: 1419-1425.
[5] Sgro C,Clinard F,Ouazir K,et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology,2002,36: 451-455.
[6] 陈富琴,陈章,张俊然,等.药物性肝损害临床流行病学研究进展.药物流行病学杂志,2016,25:810-813, 818.
[7] 杨翠翠,张丽霄,秦静静,等.从不同决策主体角度测算分析药物性肝损伤的相关成本.中国药房,2017,28:1023-1026.
[8] Sgro C,Clinard F,Quazir K,et al. Incidence of drug-induced hepatic injuries:a French population-based study. Hepatology,2002,36:451-455.
[9] 周媛. 中国人群药物性肝损害的流行病学:系统分析患者21789例.第三军医大学,2013.
[10] 朱云. 药物性肝损伤临床特征及治疗预后分析.中国人民解放军医学院,2015.
[11] 郑新,卢雄才,秦小莲,等.我国2007至2016年儿童药物性肝损伤文献分析.中国药房,2017,28: 4507-4510.
[12] 甘雨,董漪,张鸿飞,等.184例儿童药物性肝损伤的临床特征及转归状况评价.临床肝胆病杂志,2015,31: 1244-1247.
[13] 段雪飞,张亦瑾,钱芳,等. 老年人急性药物性肝损伤的病因及临床特点分析.中华临床医师杂志(电子版),2012,6: 3972-3975.
[14] 王悦之,张玉.老年药物性肝损伤的研究进展.临床肝胆病杂志,2016,32: 821-824.
[15] 张盛,熊枝繁. 药物性肝病的研究进展. 中国民康医学,2013,25: 87-91,121.
[16] 刘丽萍,郑松柏. 药物性肝损伤的流行病学研究现状. 中国新药与临床杂志,2017,36: 380-384.
[17] 李晨,辛绍杰,游绍莉.中草药致肝损害研究进展.实用肝脏病杂志,2013,16: 278-281.
[18] 李丰衣,李筠,肖小河.中药药物性肝损害的研究现状.中华中医药杂志,2009,24: 265-269.
[19] 沈弢,段昭君,庄辉.药物性肝损伤的流行病学.肝脏,2015,20: 819-823.
[20] 沈弢,黄昕,王誉雅,等.我国药物性肝损伤流行病学研究现状.临床肝胆病杂志,2018,34: 1152-1155.
[21] 肖小河,李秀惠,朱云,等.中草药相关肝损伤临床诊疗指南.临床肝胆病杂志,2016,32: 835-843.
[22] 中药药源性肝损伤临床评价技术指导原则.临床肝胆病杂志,2018,34: 1403-1409. |
